Quality of Awakening and Impact on Cognitive Function After Administration of Sugammadex in Robotic Radical Cystectomy
NACompletedINTERVENTIONAL
Enrollment
120
Participants
Timeline
Start Date
March 31, 2015
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
Conditions
Anesthesiology Management
Interventions
DRUG
sugammadex
DRUG
Neostigmine
Trial Locations (1)
00144
Regina Elena Cancer Institute, Rome
All Listed Sponsors
lead
Regina Elena Cancer Institute
OTHER
NCT02454504 - Quality of Awakening and Impact on Cognitive Function After Administration of Sugammadex in Robotic Radical Cystectomy | Biotech Hunter | Biotech Hunter